Comparative analysis reveals fatal outcomes linked to combined opportunistic infections in patients with HIV and tuberculosis.
Key Points
Combined opportunistic infections were found in 70.2% of patients with HIV-associated tuberculosis, negatively impacting prognosis.
Fatal outcomes were observed in 39 patients with HIV-associated tuberculosis, attributed primarily to tuberculosis itself and opportunistic infections.
CD4 lymphocyte levels were significantly lower in patients with HIV-associated tuberculosis compared to those without, indicating higher vulnerability.
A notable percentage, 57.9%, of patients with HIV-associated tuberculosis did not receive antiretroviral therapy, contributing to lethal outcomes.